SELLAS Life Sciences Gr (SLS) Stock Price, Quote, News & History | Benzinga

SELLAS Life Sciences Group Inc (SLS) Stock Price, Quote, News & History

SLSNASDAQ

Trade with Public

Trade with Public

$14.32

-1.14-7.34%

At close: Aug 24, 5:00 PM EST

$14.33

0.0050.03%

After Hours: 5:11 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$15.48

Close

$14.33

Volume / Avg.

8.79M / 9.01M

Day Range

$13.91 - $15.48

52 Wk Range

1.39 - 15.88

Market Cap

$2.89B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

61

Short Interest

27.33%

Days to Cover

7.89

Recent Sellas Life Sciences Group Inc News

ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Moving Higher On Friday

US stocks lower, Nasdaq falls 400 pts. ManpowerGroup shares rise after upbeat earnings. Other big gainers: PHOE, SG, TRVI, DCBO, ZNTL, GPRE, SLS, FEIM, TRV, BHVN, KOS, BJRI, MBX.

Avi Kapoor

SELLAS Life Sciences Shares Slip Wednesday as Price Tests $16 Resistance Wall

SELLAS Life Sciences Group shares are trading lower Wednesday as investors take profits, with risk appetite softer across equities.

Henry Khederian

SELLAS Life Sciences Shares Fall Tuesday: What's Driving The Move?

SELLAS Life Sciences shares are trading lower Tuesday as traders digest a breakout run, with momentum still elevated from the latest update.

Henry Khederian

Sellas Life Sciences Shares Break Out To New 52-Week High: What's Driving The Momentum?

SELLAS Life Sciences shares are trading higher by about 24% on Monday as the stock extends a breakout run that has traders focused on fresh highs and corporate updates.

Henry Khederian

Iridium Communications, FuelCell Energy, Rocket Lab And Other Big Stocks Moving Higher On Monday

Dow Jones gains 350 points, Iridium acquired by Rocket Lab for $8B, big stocks recording gains: QuidelOrtho, FuelCell, Ouster, Viasat, Swarmer, Charter, Prime Medicine, Roblox, Satellogic, Churchill Capital, Rocket Lab.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-28.42M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

141.47M

Free Cash Flow (TTM)

-28.42M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

113.05M

Analyst Trends and Forecast

1

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.99B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

22.69

Earnings Yield % (TTM)

-1.42%

Earnings Yield % (FWD)

-1.33%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.68

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$138.34M

Debt to Equity

0.01

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$15.48

Close

$14.33

Volume / Avg.

8.79M / 9.01M

Day Range

$13.91 - $15.48

52 Wk Range

1.39 - 15.88

Market Cap

$2.89B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

61

Short Interest

27.33%

Days to Cover

7.89

About

Sector

Health Care

Industry

Biotechnology

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a p...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy SELLAS Life Sciences Gr (SLS) stock?

A

You can purchase shares of SELLAS Life Sciences Gr (NASDAQ:SLS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are SELLAS Life Sciences Gr (SLS) competitors?

A

Other companies in SELLAS Life Sciences Gr’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for SELLAS Life Sciences Gr (SLS) stock?

A

SELLAS Life Sciences Gr has a consensus price target of $6.50.

Q

What is the current price for SELLAS Life Sciences Gr (SLS)?

A

The stock price for SELLAS Life Sciences Gr (NASDAQ: SLS) is $14.33 last updated August 24, 2026 at 5:11 PM EDT.

Q

Does SELLAS Life Sciences Gr (SLS) pay a dividend?

A

There are no upcoming dividends for SELLAS Life Sciences Gr.

Q

When is SELLAS Life Sciences Gr (NASDAQ:SLS) reporting earnings?

A

SELLAS Life Sciences Gr does not have any upcoming earnings scheduled.

Q

Is SELLAS Life Sciences Gr (SLS) going to split?

A

There is no upcoming split for SELLAS Life Sciences Gr.

Q

What sector and industry does SELLAS Life Sciences Gr (SLS) operate in?

A

SELLAS Life Sciences Gr is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.